{"id":1009533,"date":"2020-07-30T11:54:37","date_gmt":"2020-07-30T09:54:37","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1009533"},"modified":"2020-07-30T11:58:01","modified_gmt":"2020-07-30T09:58:01","slug":"dompe-x-therapeutics-in-usa","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/dompe-x-therapeutics-in-usa\/","title":{"rendered":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA"},"content":{"rendered":"<p>photo by dompe.com<\/p>\n<p>&nbsp;<\/p>\n<p>Mauro Ferrari \u00e8 il nuovo Presidente &amp; CEO della neonata Domp\u00e9 X-Therapeutics (DXT), dedicata allo sviluppo della nuova generazione di terapie che unsicono AI, matematica multiscala, nanotecnologie e farmaceutica. Lo scopo aziendale \u00e8 quello di creare nuove metodologie per personalizzare alcuni tipi di malattie.<\/p>\n<p>La sede della nuova azienda sar\u00e0 San Francisco, dove Domp\u00e9 \u00e8 gia presente dal 2018. Il gruppo ha gi\u00e0 uan rete di open innovation che coinvolge diversi centri importanti in tutto il mondo (Harvard, Houston Methodist e Stanford, tra gli altri).<\/p>\n<p>DTX utilizzer\u00e0 il know how italiano sviluppato nell&#8217;ambito del supercalcolo con Exscalate e in quello delle biotecnologie. Le attivit\u00e0 riguarderanno la medicina traslazionale, che permette di arrivare alla scoperta di nuovi trattamenti utilizzando un approccio mutlidisciplinare. I primi risultati, come ha dichiarato Ferrari ad una giornalista del Corriere Della Sera, potrebbero arrivare gi\u00e0 per il 2021, con l&#8217;incubazione di due tecnologie e il potenziamento della rete di contri di ricerca con cui collaborare.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>photo by dompe.com &nbsp; Mauro Ferrari \u00e8 il nuovo Presidente &amp; CEO della neonata Domp\u00e9 X-Therapeutics (DXT), dedicata allo sviluppo della nuova generazione di terapie che unsicono AI, matematica multiscala, nanotecnologie e farmaceutica. Lo scopo aziendale \u00e8 quello di creare nuove metodologie per personalizzare alcuni tipi di malattie. La sede della nuova azienda sar\u00e0 San Francisco, dove Domp\u00e9 \u00e8 gia presente dal 2018. Il gruppo ha gi\u00e0 uan rete di open innovation che coinvolge diversi centri importanti in tutto il&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1009535,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[2786,2853,2854,2665],"class_list":["post-1009533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-dompe","tag-dtx","tag-terapie-innovative","tag-usa"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by dompe.com &nbsp; Mauro Ferrari \u00e8 il nuovo Presidente &amp; CEO della neonata Domp\u00e9 X-Therapeutics (DXT), dedicata allo sviluppo della nuova generazione di terapie che unsicono AI, matematica multiscala, nanotecnologie e farmaceutica. Lo scopo aziendale \u00e8 quello di creare nuove metodologie per personalizzare alcuni tipi di malattie. La sede della nuova azienda sar\u00e0 San Francisco, dove Domp\u00e9 \u00e8 gia presente dal 2018. Il gruppo ha gi\u00e0 uan rete di open innovation che coinvolge diversi centri importanti in tutto il...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-30T09:54:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-30T09:58:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"846\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA\",\"datePublished\":\"2020-07-30T09:54:37+00:00\",\"dateModified\":\"2020-07-30T09:58:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/\"},\"wordCount\":169,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Exscalate2.jpg\",\"keywords\":[\"dompe\",\"dtx\",\"terapie innovative\",\"usa\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/\",\"name\":\"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Exscalate2.jpg\",\"datePublished\":\"2020-07-30T09:54:37+00:00\",\"dateModified\":\"2020-07-30T09:58:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Exscalate2.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/Exscalate2.jpg\",\"width\":1500,\"height\":846},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/dompe-x-therapeutics-in-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/","og_locale":"en_US","og_type":"article","og_title":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners","og_description":"photo by dompe.com &nbsp; Mauro Ferrari \u00e8 il nuovo Presidente &amp; CEO della neonata Domp\u00e9 X-Therapeutics (DXT), dedicata allo sviluppo della nuova generazione di terapie che unsicono AI, matematica multiscala, nanotecnologie e farmaceutica. Lo scopo aziendale \u00e8 quello di creare nuove metodologie per personalizzare alcuni tipi di malattie. La sede della nuova azienda sar\u00e0 San Francisco, dove Domp\u00e9 \u00e8 gia presente dal 2018. Il gruppo ha gi\u00e0 uan rete di open innovation che coinvolge diversi centri importanti in tutto il...","og_url":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/","og_site_name":"Frezza Partners","article_published_time":"2020-07-30T09:54:37+00:00","article_modified_time":"2020-07-30T09:58:01+00:00","og_image":[{"width":1500,"height":846,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA","datePublished":"2020-07-30T09:54:37+00:00","dateModified":"2020-07-30T09:58:01+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/"},"wordCount":169,"image":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","keywords":["dompe","dtx","terapie innovative","usa"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/","url":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/","name":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","datePublished":"2020-07-30T09:54:37+00:00","dateModified":"2020-07-30T09:58:01+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2020\/07\/Exscalate2.jpg","width":1500,"height":846},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/dompe-x-therapeutics-in-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Domp\u00e9 X-Therapeutics (DTX) e le terapie innovative negli USA"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1009533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1009533"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1009533\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1009535"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1009533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1009533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1009533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}